Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States.
ACS Nano. 2013 Mar 26;7(3):2161-71. doi: 10.1021/nn3057565. Epub 2013 Feb 13.
Understanding how a magnetic field affects the interaction of magnetic nanoparticles (MNPs) with cells is fundamental to any potential downstream applications of MNPs as gene and drug delivery vehicles. Here, we present a quantitative analysis of how a pulsed magnetic field influences the manner in which MNPs interact with and penetrate across a cell monolayer. Relative to a constant magnetic field, the rate of MNP uptake and transport across cell monolayers was enhanced by a pulsed magnetic field. MNP transport across cells was significantly inhibited at low temperature under both constant and pulsed magnetic field conditions, consistent with an active mechanism (i.e., endocytosis) mediating MNP transport. Microscopic observations and biochemical analysis indicated that, in a constant magnetic field, transport of MNPs across the cells was inhibited due to the formation of large (>2 μm) magnetically induced MNP aggregates, which exceeded the size of endocytic vesicles. Thus, a pulsed magnetic field enhances the cellular uptake and transport of MNPs across cell barriers relative to a constant magnetic field by promoting accumulation while minimizing magnetically induced MNP aggregation at the cell surface.
了解磁场如何影响磁性纳米粒子(MNPs)与细胞的相互作用,对于将 MNPs 作为基因和药物输送载体的任何潜在下游应用都是至关重要的。在这里,我们对脉冲磁场如何影响 MNPs 与细胞单层相互作用和穿透的方式进行了定量分析。与恒磁场相比,脉冲磁场增强了 MNPs 在细胞单层中的摄取和转运速率。在恒磁场和脉冲磁场条件下,低温显著抑制了 MNP 在细胞间的转运,这与一种主动机制(即胞吞作用)介导 MNP 转运一致。显微镜观察和生化分析表明,在恒磁场中,由于形成了大于 2 μm 的大的磁诱导 MNPs 聚集体,从而超过了内吞小泡的大小,导致 MNPs 在细胞间的转运受到抑制。因此,与恒磁场相比,脉冲磁场通过促进积累,同时最大限度地减少细胞表面的磁诱导 MNPs 聚集,增强了 MNPs 穿过细胞屏障的细胞摄取和转运。
Cell Biochem Biophys. 2019-5-21
Nanotechnology. 2018-3-2
Int J Nanomedicine. 2020-6-11
Nanomedicine (Lond). 2014-3-19
World J Stem Cells. 2022-7-26
Nanomaterials (Basel). 2021-10-17
Nanomaterials (Basel). 2021-3-13
Bioengineered. 2020-12
Nanoscale Res Lett. 2008-10-2
Trends Biotechnol. 2011-4-12
Adv Drug Deliv Rev. 2010-8-13